Investigation of bioterrorism-related anthrax, United States, 2001: Epidemiologic findings

Emerging Infectious Diseases

Volumn 8, Issue 10, 2002, Pages 1019-1028

  Jernigan, Daniel B ^a   Raghunathan, Pratima L ^a   Bell, Beth P ^a   Brechner, Ross ^a   Bresnitz, Eddy A ^b   Butler, Jay C ^c   Cetron, Marty ^c   Cohen, Mitch ^c   Doyle, Timothy ^d   Fischer, Marc ^d   Greene, Carolyn ^a   Griffith, Kevin S ^a   Guarner, Jeannette ^a   Hadler, James L ^a   Hayslett, James A ^a   Meyer, Richard ^a   Petersen, Lyle R ^a   Phillips, Michael ^h   Pinner, Robert ^a   Popovic, Tanja ^a   Quinn, Conrad P ^g   Reefhuis, Jennita ^a   Reissman, Dori ^a   Rosenstein, Nancy ^h   Schuchat, Anne ^a   Shieh, Wun Ju ^e   Siegal, Larry ^a   Swerdlow, David L ^a   Tenover, Fred C ^f   Traeger, Marc ^a   Ward, John W ^g   Weisfuse, Isaac ^a   Wiersma, Steven ^a   Yeskey, Kevin ^a   Zaki, Sherif ^a   Ashford, David A ^a   Perkins, Bradley A ^a   Ostroff, Steve ^a   Hughes, James ^a   Fleming, David ^a   Koplan, Jeffrey P ^a   Gerberding, Julie L ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Maryland State Department of Health and Mental Hygiene   (United States)

^c NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^d CDC   (United States)

^e District of Columbia Department of Health   (United States)

^f NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^g FLORIDA DEPARTMENT OF HEALTH   (United States)

^h NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACILLUS ANTHRACIS; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOLOGICAL WARFARE; CASE FINDING; HUMAN; INFECTION CONTROL; POSTAL MAIL; UNITED STATES; WORKPLACE;

EID: 0036775222     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0810.020353     Document Type: Article

References (44)

1. Brachman P, Kaufmann A. Anthrax. In: Evans A, Brachman P, editors. Bacterial Infections of Humans. New York: Plenum Medical Book Company; 1998. p. 95-107.
2. Suffin SC, Carnes WH, Kaufmann AF. Inhalation anthrax in a home craftsman. Hum Pathol 1978;9:594-7.
3. Centers for Disease Control and Prevention. Human anthrax associated with an epizootic among livestock - North Dakota, 2000. MMWR Morb Mortal Wkly Rep 2001;50:677-80.
4. Plotkin SA, Brachman PS, Utell M, Bumford FH, Atchison MM. An epidemic of inhalation anthrax, the first in the twentieth century: I. Clinical features. This article was originally published in Am J Med 1960;29:992-1001. Am J Med 2002;112:4-12.
5. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994;266:1202-7.
6. Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, et al. Anthrax as a biological weapon: Medical and public health management. Working Group on Civilian Biodefense. JAMA 1999;281:1735-45.
7. Centers for Disease Control and Prevention. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:889-93.
8. Turnbull PC. Definitive identification of Bacillus anthracis - A review. J Appl Microbiol 1999;87:237-40.
9. Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis 2002;8:1103-10.
10. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933-44.
11. Centers for Disease Control and Prevention. Procedures for Collecting Surface Environmental Samples for Culturing Bacillus Anthracis. Available from: URL: http://www.bt.cdc.gov/DocumentsApp/Anthrax/11132001/final42.asp. Accessed November 2001.
12. Centers for Disease Control and Prevention. Evaluation of Bacillus anthracis contamination inside the Brentwood Mail Processing and Distribution Center - District of Columbia, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:1129-33.
13. Centers for Disease Control and Prevention, American Society for Microbiology, Association of Public Health Laboratories. Basic Diagnostic Testing Protocols for Level A Laboratories for the Presumptive Identification of Bacillus Anthracis. Available from: URL: http://www.asmusa.org/pcsrc/ban.asm.la.cp.102401f.pdf. Accessed October 2001.
14. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. 11th Informational Supplement M100-S11. Wayne, Pennsylvania: The Committee; 2001.
15. Keim P, Price LB, Klevytska AM, Smith KL, Schupp JM, Okinaka R, et al. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships with Bacillus anthracis. J Bacteriol 2000;182:2928-36.
16. Centers for Disease Control and Prevention. Suspected cutaneous anthrax in a laboratory worker - Texas, 2002. MMWR Morb Mortal Wkly Rep 2002;51:279-81.
17. Hoffmaster AR, Fitzgerald CC, Ribot E, Mayer LW, Popovic T. Molecular subtyping of Bacillus anthracis and the 2001 bioterrorism-associated anthrax outbreak, United States. Emerg Infect Dis 2002;8:1111-6.
18. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:909-19.
19. Mohammed MJ, Marston CK, Popovic T, Weyant RS, Tenover FC. Antimicrobial susceptibility testing of Bacillus anthracis: Comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J Clin Microbiol 2002;40:1902-7.
20. Federal Bureau of Investigation. Photos of Anthrax Letters to NBC, Senator Daschle, and NY Post. Available from: URL: http://www.fbi.gov/pressre1/pressre101/102301.htm. Accessed May 15, 2002.
21. Greene CM, Reefhuis J, Tan C, Fiore AE, Goldstein S, Beach MJ, et al. Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001. Emerg Infect Dis 2002;8:1048-55.
22. Tan CG, Sandhu HS, Crawford DC, Redd SC, Beach MJ, Buehler J, et al. Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001. Emerg Infect Dis 2002;8:1073-7.
23. Traeger MS, Wiersma ST, Rosenstein NE, Malecki JM, Shepard CW, Raghunathan PL, et al. First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001. Emerg Infect Dis 2002;8:1029-34.
24. Hsu VP, Lukacs SL, Handzel T, Hayslett J, Harper S, Hales T, et al. Opening a Bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: The public health response. Emerg Infect Dis 2002;8:1039-43.
25. Dewan PK, Fry AM, Laserson K, Tierney BC, Quinn CP, Hayslett JA, et al. Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis 2002;8:1066-72.
26. Centers for Disease Control and Prevention. Interim guidelines for investigation of and response to Bacillus anthracis exposures. MMWR Morb Mortal Wkly Rep 2001;50:987-90.
27. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax, 2001. MMWR Morb Mortal Wkly Rep 2001;50:1008-10.
28. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. MMWR Morb Mortal Wkly Rep 2001;50:973-6.
29. Centers for Disease Control and Prevention. Additional options for preventive treatment for persons exposed to inhalational anthrax. MMWR Morb Mortal Wkly Rep 2001;50:1142-1151.
30. Shepard CW, Soriano-Gabarro M, Zell ER, Hayslett J, Lukacs S, Goldstein S, et al. Antimicrobial postexposure prophylaxis for anthrax: Adverse events and adherence. Emerg Infect Dis 2002;8:1124-32.
31. Jefferds MD, Laserson K, Fry AM, Roy S, Hayslett J, Grummer-Strawn L, et al. Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001. Emerg Infect Dis 2002;8:1138-44.
32. Williams JL, Noviello SS, Griffith KS, Wurtzel H, Hamborsky J, Perz JF, et al. Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001. Emerg Infect Dis 2002;8:1133-7.
33. Brachman P, Friedlander A. Inhalation anthrax. Ann N Y Acad Sci 1980;353:83-93.
34. Brookmeyer R, Blades N. Prevention of inhalational anthrax in the U.S. outbreak. Science 2002;295:1861.
35. Broad WJ, Johnston D. Anthrax sent through mail gained potency by the letter. The New York Times 2002 May 7.
36. Collingwood J. F.B.I.'s anthrax inquiry. The New York Times 2002 May 18.
37. Ashford DA, Rotz LD, Perkins BA. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR Morb Mortal Wkly Rep 2000;49(No. RR-15).
38. Centers for Disease Control and Prevention. Bioterrorism alleging use of anthrax and interim guidelines for management - United States, 1998. MMWR Morb Mortal Wkly Rep 1999;48:69-74.
39. Brachman PS, Plotkin SA, Bumford FH, Atchison MA. An epidemic of inhalation anthrax. 11. Epidemiologic investigation. Am J Hyg 1960;72:6-23.
40. Barakat LA, Quentzel HL, Jernigan JA, Kirschke DL, Griffith K, Spear SM, et al. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA 2002;287:863-8.
41. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax - Connecticut, 2001. MMWR Morb Mortal Wkly Rep 2001;50:1077-9.
42. Webb GF, Blaser MJ. Mailborne transmission of anthrax: Modeling and implications. Proc Natl Acad Sci USA 2002;99:7027-32.
43. Gerberding JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: Clinicians and public health agencies as essential partners. JAMA 2002;287:898-900.
44. Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Anthrax as a biological weapon, 2002: Updated recommendations for management. JAMA 2002;287:2236-52.